Loss of p14(ARF) in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)

Nature Medicine

Volumn 6, Issue 10, 2000, Pages 1128-1133

  Ries, Stefan J ^a   Brandts, Christian H ^a   Chung, Alicia S ^a   Biederer, Carola H ^a   Hann, Byron C ^a   Lipner, Ettie M ^a   McCormick, Frank ^a   Michael Korn, W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P14ARF;

ADENOVIRUS; ADULT; ARTICLE; GENE MUTATION; GENE REPLICATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; TUMOR CELL; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; VIROLOGY;

ADENOVIRIDAE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 0033623250     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/80466     Document Type: Article

References (34)

1. Clonal analysis of human colorectal tumors
2. Implications of the p53 tumor-suppressor gene in clinical oncology
3. p53 Status and the efficacy of cancer therapy in vivo
4. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
5. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection
6. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
7. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
8. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
9. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
10. p53 Status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection
11. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status
12. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells
13. p53-Independent and -dependent requirements for E18-55K in adenovirus type 5 replication
14. Mdm2: Keeping p53 under control
15. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
16. The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53
17. p21 Is necessary for the p53-mediated G1 arrest in human cancer cells
18. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
19. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip 1 in normal human fibroblasts
20. Mdm2 expression is induced by wild type p53 activity
21. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
22. p14(ARF) links the tumour suppressors RB and p53
23. E1A signaling to p53 involves the p19(ARF) tumor suppressor
24. Nucleolar Arf seqesters Mdm2 and activates p53
25. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
26. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
27. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells
28. The CDK inhibitor p21(WAF/Cip1) is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells
29. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
30. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor
31. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
32. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
33. p53-Dependent cell death/apoptosis is required for a productive adenovirus infection
34. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport